OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stepwise Coordination-Driven Metal–Phenolic Nanoparticle as a Neuroprotection Enhancer for Alzheimer’s Disease Therapy
Zhihui Yin, Zhixin Zhang, Demin Gao, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 524-540
Closed Access | Times Cited: 19

Showing 19 citing articles:

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 30

Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 25

Multifunctional Nanocarrier for Synergistic Treatment of Alzheimer’s Disease by Inhibiting β-Amyloid Aggregation and Scavenging Reactive Oxygen Species
Chenchen Wang, Xiaolei Song, Peng Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 21, pp. 27127-27138
Closed Access | Times Cited: 13

Interactions between nanoparticles and pathological changes of vascular in Alzheimer’s disease
Ting Lei, Zixiao Yang, Hanmei Li, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115219-115219
Closed Access | Times Cited: 10

Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17

Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease
Aihua Xie, Guowang Cheng, Jiaxin Wu, et al.
Biomaterials (2024) Vol. 312, pp. 122749-122749
Closed Access | Times Cited: 8

Transthyretin-Penetratin: A Potent Fusion Protein Inhibitor against Alzheimer’s Amyloid-β Fibrillogenesis with High Blood Brain Barrier Crossing Capability
Ying Wang, Wei Liu, Yan Sun, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 3, pp. 419-431
Closed Access | Times Cited: 6

Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access

ROS-related nanoparticles for the management of Alzheimer’s disease: Wielding the double-edged sword
Yibin Yu, Qi Zhang, Yihao Guo, et al.
Chemical Engineering Journal (2025), pp. 161784-161784
Closed Access

Neuronal Membrane-Coated Mesoporous Ceria Nanoparticles for Blood–Brain Barrier Crossing and Mitigation of Neurodegeneration
Rafquat Rana, Shourya Tripathi, Keerti Mishra, et al.
ACS Applied Nano Materials (2025)
Closed Access

Advances in the study of polydopamine nanotechnology in central nervous system disorders
Sijing Ren, Xiangyu Xiao, Jiahua Lv, et al.
Frontiers in Materials (2024) Vol. 11
Open Access | Times Cited: 3

Functionalization of and through Melanin: Strategies and Bio-Applications
Alexandra Mavridi‐Printezi, Arianna Menichetti, Dario Mordini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9689-9689
Open Access | Times Cited: 6

Design of aggregation-induced emission-active fluorogen-based nanoparticles for imaging and scavenging Alzheimer's β-amyloid by photo-oxygenation
Luqi Liu, Wei Liu, Yan Sun, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 37, pp. 8994-9004
Closed Access | Times Cited: 6

Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer’s Disease
Dhairiya Agarwal, Sumit Kumar, Ramesh Ambatwar, et al.
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 2, pp. 219-242
Closed Access

Di-caffeoylquinic acid: a potential inhibitor for amyloid-beta aggregation
Yue Sun, Xue Wang, Xiaoyu Zhang, et al.
Journal of Natural Medicines (2024) Vol. 78, Iss. 4, pp. 1029-1043
Closed Access

Page 1

Scroll to top